Evaluation of PK and Safety of D-0120 and Allopurinol
NCT05360628
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
D-0120 in combination with Allopurinol
Sponsor
InventisBio Co., Ltd